Stratatech: StratGraft's Skin Treatment Gets New FDA Regenerative Med Status

A regenerative medicine treatment for skin burns developed by Stratatech could make it to the market more quickly following a regulatory decision announced Tuesday. The FDA has designated StrataGraft, a Stratatech-developed sheet of living tissue made from human cells that form into skin, as a Regenerative Medicine Advanced Therapy (RMAT), the company said. Drugs that [...]